Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Will genetics really revolutionize the drug discovery process?

L M Gelbert1, R E Gregg

  • 1Applied Genomics and Metabolic Diseases, Bristol-Myers Squibb Company, Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA. Gelbert@bms.com

Current Opinion in Biotechnology
|January 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An arterial anomaly in the fetal pig.

The Anatomical record·2010
Same author

Optimized blood cell profiling method for genomic biomarker discovery using high-density microarray.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2005
Same author

Using 12-lead ECG and synthesized VCG in detection of right ventricular hypertrophy with terminal right conduction delay versus partial right bundle branch block in the pediatric population.

Journal of electrocardiology·2002
Same author

Beta 3 agonists. Part 1: evolution from inception to BMS-194449.

Bioorganic & medicinal chemistry letters·2001
Same author

A genetic analysis of the London strain of rainbow trout.

Animal genetics·2001
Same author

Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity.

Journal of cardiovascular pharmacology·1999
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

New genetic technologies will revolutionize drug discovery by identifying novel targets and improving disease investigation. Whole genome sequencing and gene function analysis will enhance target selection for developing new medicines.

Area of Science:

  • Genomics and Bioinformatics
  • Pharmacogenomics
  • Molecular Biology

Background:

  • Genetics has historically played a limited role in pharmaceutical research and development.
  • Advancements in genetic technologies are poised to significantly impact drug discovery pipelines.

Purpose of the Study:

  • To highlight the transformative potential of emerging genetic technologies in drug discovery.
  • To outline how new methods will improve target identification and validation.
  • To discuss the integration of genetic information into drug development strategies.

Main Methods:

  • Whole genome sequencing for identifying novel drug targets.
  • Gene function determination assays for robust target selection.
  • Single nucleotide polymorphism (SNP) and polymorphism analysis for polygenic disease research.

Related Experiment Videos

  • Oligonucleotide array technologies for gene expression profiling.

    • Main Results:

    • Identification of new drug discovery targets through comprehensive genomic analysis.
    • Enhanced ability to select validated targets by understanding gene function.
    • Improved investigation of complex genetic disorders and personalized medicine approaches.
    • Novel insights into gene expression patterns relevant to drug response.

    Conclusions:

    • Emerging genetic technologies are set to significantly advance drug discovery.
    • Integration of genomic data will lead to more effective and targeted therapeutics.
    • The future of drug development will be increasingly driven by genetic insights.